Welcome to our dedicated page for Ehealth SEC filings (Ticker: EHTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The eHealth, Inc. (NASDAQ: EHTH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a public company in the insurance agencies and brokerages industry, eHealth uses SEC filings to report material events, financial results, governance changes, and capital structure developments that are relevant to investors evaluating EHTH stock.
eHealth regularly files current reports on Form 8-K to announce significant developments. Recent 8-K filings describe quarterly financial results, including press releases for the second and third quarters of a fiscal year, and provide information about the company’s financial condition. Other 8-Ks document amendments to credit agreements, such as an extension of the maturity date of a term loan credit agreement with Blue Torch Finance LLC and the entry into a new asset-based revolving credit facility with Manulife | Comvest Credit Partners, along with the use of proceeds to repay existing debt and support strategic initiatives.
Filings also address corporate governance and compensation matters. eHealth has reported on amendments and restatements of its bylaws, including changes to meeting notice deadlines, definitions relevant to principal competitors, and provisions related to indemnification and insurance for directors, officers, employees and agents. Other filings discuss the approval and amendment of equity incentive plans, inducement and equity awards for executives and directors, and the results of stockholder votes on director elections, executive compensation, and plan amendments.
Leadership changes and board composition are another focus of eHealth’s SEC reports. Form 8-K filings describe CEO transition arrangements, the appointment of a new chief executive officer, related severance and compensation agreements, and the resignation and appointment of directors, including those designated under an investment agreement with a preferred stock investor. These disclosures help investors understand how management and board oversight are evolving.
On Stock Titan, eHealth’s SEC filings are paired with AI-powered summaries that help explain the contents of lengthy documents such as 8-Ks and, where available, annual reports on Form 10-K, quarterly reports on Form 10-Q, and proxy statements. Real-time updates from EDGAR ensure that new filings, including any insider transaction reports on Form 4 or other material disclosures, are quickly reflected. The AI summaries highlight key points, such as changes in capital structure, governance updates, and important risk or operational information, allowing users to review the implications for EHTH without reading every line of each filing.
By using this filings page, investors can efficiently review eHealth’s regulatory history, track recurring themes in its disclosures, and connect filing information with the company’s news releases and business description. This context can support deeper analysis of eHealth’s financial performance, risk profile, and strategic direction as presented in its official SEC documents.
Insider Form 4 summary: Francis S. Soistman Jr., a director of eHealth, Inc. (EHTH), reported a transaction dated 09/22/2025 showing 1,709 shares of common stock disposed at a price of $3.97 per share. The filing states these shares were withheld to satisfy tax withholding obligations. After the transaction, Mr. Soistman beneficially owned 778,773 shares and the ownership is reported as direct. The Form 4 is signed by an attorney-in-fact on behalf of Mr. Soistman on 09/24/2025 and includes Exhibit 24 (Power of Attorney).
eHealth, Inc. (EHTH) reported an insider grant to director Todd Arden: an initial award of 38,592 restricted stock units (RSUs) was granted on 09/17/2025. Each RSU represents a contingent right to one share of common stock upon vesting. The RSUs vest in three equal annual installments beginning on the vesting commencement date of 09/17/2025, subject to the director's continued service through each vesting date. The award includes a 100% vesting acceleration if the company is subject to a change in control prior to the termination of the individual's service. The reported ownership after the transaction is 38,592 shares beneficially owned directly by the reporting person.
eHealth, Inc. director Todd Arden submitted an initial Form 3 reporting his relationship to the issuer and stating he beneficially owns no securities of EHTH. The filing lists the event date as 09/17/2025 and is signed by an attorney-in-fact on 09/19/2025. The report is an individual filing and identifies Arden's address at the company office in Austin, TX.
eHealth, Inc. (EHTH) director and Chief Executive Officer Derrick A. Duke reported beneficial ownership of 300,000 shares of common stock, held directly. The reported amount includes 300,000 unvested restricted stock units (RSUs) that vest in three equal annual installments through the three-year anniversary of the award's vesting commencement date of August 4, 2025, contingent on continued service. The filing records the Form 3 initial ownership disclosure.
eHealth, Inc. reported changes to its Board of Directors. On September 17, 2025, Aaron Tolson resigned from the Board and from the Compensation, Nominating, and Government and Regulatory Affairs Committees. His resignation is stated not to result from any disagreement with the company.
The Board immediately appointed Todd Arden, a designee of H.I.G. under an existing investment agreement, to fill the vacancy as a Class I director with a term ending at the 2028 annual meeting. He also joined the same three committees. Arden received time-based restricted stock units valued at $150,000, vesting in three equal annual installments, and will receive pro rata portions of the standard cash retainers for Board and committee service.
On September 18, 2025, the Board expanded its size from nine to ten directors and appointed Derrick Duke as a Class I director, also serving until the 2028 annual meeting. The company notes there are no required related-party or family relationship disclosures for either Arden or Duke.
Goldman Sachs reports beneficial ownership of 767,063.28 shares of eHealth common stock, representing 2.5% of the outstanding class. The filing shows no sole voting or dispositive power and records shared voting power of 766,913.28 shares and shared dispositive power of 767,063.28 shares, indicating control of these shares is exercised jointly rather than individually. The Schedule 13G/A states the holdings are held in the ordinary course of business and not for the purpose of changing or influencing control. A joint filing agreement and an exhibit identifying Goldman Sachs & Co. LLC as the relevant subsidiary are attached.
John J. Dolan, identified as Chief Financial Officer of eHealth, Inc. (EHTH), reported a transaction dated 08/10/2025 in which 1,499 shares of common stock were withheld to satisfy a tax withholding obligation. The filing shows a per‑share price of $3.45 and reports that following the withholding Mr. Dolan beneficially owns 199,498 shares. The Form 4 was submitted as a single reporting person filing and the signature block shows the form was signed by an attorney‑in‑fact, Sonwha Lee, on 08/12/2025. The document presents this action as a routine withholding related to compensation or award settlement rather than an open‑market purchase or sale.
eHealth, Inc. (Nasdaq: EHTH) has filed a universal shelf registration (Form S-3) covering up to $300 million of securities. The shelf allows the company to issue, in one or more future offerings, common or preferred stock, debt, depositary shares, warrants, subscription rights, purchase contracts or units. Offerings may be executed directly, or through agents, dealers or underwriters, with terms and pricing disclosed in subsequent prospectus supplements.
Management says net proceeds will be used for working capital, general corporate purposes and possible acquisitions, but retains broad discretion. The filing classifies eHealth as an accelerated filer and smaller reporting company; it is not an emerging-growth company. No new financial results accompany this statement—risk factors and financials are incorporated by reference.
Investor takeaways: the shelf greatly increases capital-raising flexibility and could bolster liquidity, yet any equity issuance would dilute existing shareholders. Timing, size and structure of specific offerings remain unknown until a supplement is filed.